MDS Pharma Services Expands Clinical Research Capabilities in Asia Pacific

MDS Pharma Services, a provider of drug discovery and development solutions headquartered in Montreal, announced the opening of new clinical development facilities in Sydney, Australia and Petaling Jaya, Malaysia. In addition to the two new facilities, MDS Pharma Services’ presence in the Asia-Pacific region also includes central lab and global clinical development services in China and Singapore, centralized ECG services based in Singapore serving Asia and Australia, field-based capabilities in Thailand and pharmacology services in Taiwan. The company also has established partnerships for phase II-IV services in Australia, India, Japan, South Korea and New Zealand.